Medicine & Life Sciences
Azacitidine
100%
Acute Myeloid Leukemia
60%
INCB018424
46%
Phase II Clinical Trials
36%
sarcosine-arginyl-valyl-tyrosyl-isoleucyl-histidyl-prolyl-alanine
32%
fludarabine
30%
beta-hydroxyisovaleric acid
25%
eltrombopag
24%
romidepsin
24%
Chimerism
24%
Thiotepa
21%
Drug Therapy
21%
Polycythemia Vera
21%
Vorinostat
21%
Progression-Free Survival
20%
Essential Thrombocythemia
20%
Therapeutics
18%
Central Nervous System Neoplasms
18%
Cachexia
18%
Melphalan
18%
Recurrence
17%
fibrin fragment D
17%
Whole-Body Irradiation
17%
Maximum Tolerated Dose
17%
Transplants
17%
Molecular Pathology
17%
Myelodysplastic Syndromes
16%
T-Lymphocytes
16%
Survival
16%
Patient Reported Outcome Measures
16%
Hematopoietic Stem Cell Transplantation
16%
Tamoxifen
15%
Graft vs Host Disease
15%
Glutamine
15%
Clonal Evolution
15%
Feasibility Studies
15%
Allogeneic Cells
15%
Hematopoietic Stem Cells
14%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14%
Cyclophosphamide
14%
Arginine
13%
Ovarian Neoplasms
13%
Allografts
13%
Randomized Controlled Trials
12%
Longitudinal Studies
12%
Lymphoma
12%
Cell Transplantation
12%
Lung Neoplasms
11%
Steroids
11%
Meta-Analysis
11%